HIV in the Middle East and North Africa: priority, culture, and control

Alkaiyat, Abdulsalam; Weiss, Mitchell G.

doi:10.1007/s00038-013-0485-y

Cited by 24 publications

(17 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Limited HIV testing, the cost of ART to burdened health care systems, and poor access are obstacles for ART uptake and scale-up [19]. The median prevalence of lifetime HIV testing among PWID is 33% (IQR: 16–56%), and is very low in many countries with concentrated HIV epidemics such as in Afghanistan, Pakistan and Egypt [6].…”

Section: Moving Forwardmentioning

confidence: 99%

Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden?

Mumtaz

Weiss

Abu‐Raddad

2015

Journal of the International AIDS Society

View full text Add to dashboard Cite

Section: Moving Forwardmentioning

confidence: 99%

Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden?

Mumtaz

Weiss

Abu‐Raddad

2015

Journal of the International AIDS Society

View full text Add to dashboard Cite

“…Stigma drives the HIV/AIDS epidemic by creating a culture of blame and victimization [4,5,24,25]. In Nigeria, 44% of unmarried youth stated that mandatory PHT would increase the stigma of HIV/AIDS [20].…”

Section: Effects Of Stigma Associated With Hiv Infectionmentioning

confidence: 99%

“…Currently, in the United Arab Emirates (UAE) HIV is in a low prevalence stage, similarly to the entire Middle East/ North Africa (MENA) region (0.2%) [1][2][3][4][5]. From the 1980s to the end of 2012, a cumulative total of 780 HIV still alive cases (76% males) were reported among 900,000 UAE nationals [2].…”

Section: Introductionmentioning

confidence: 99%

Attitudes towards premarital HIV testing among high-school students in the United Arab Emirates, and evaluation of an educational intervention

Gańczak¹,

Barss²,

Grivna³

et al. 2017

HIV & AIDS Review

View full text Add to dashboard Cite

show abstract

“…From a public health perspective, in many countries of the MENA lack of integrated data on HIV incidence rates and disease progression among known patients requires to be increased [8] . In addition, scarcity of gender-sensitive programs and lack of systematic approach in development of national guidelines hinder enactment of new treatment strategies in MENA [4,5,13,14] . HIV epidemic is characterized by rising incidence and prevalence rates among key at-risk populations, specifically among people who inject drugs (PWIDs) [12] .…”

Section: Introductionmentioning

confidence: 99%

Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa

Sardashti

Samaei

Firouzeh

et al. 2015

WJV

View full text Add to dashboard Cite

New World Health Organization guidelines recommend the initiation of antiretroviral treatment (ART) for asymptomatic patients with CD4+ T-cell counts of ≤ 500 cells/mm 3 . Substantial reduction of human immunodeficiency virus (HIV) transmission is addressed as a major public health outcome of this new approach. Middle East and North Africa (MENA), known as the area of controversies in terms of availability of comprehensive data, has shown concentrated epidemics among most of it's at risk population groups. Serious challenges impede the applicability of new guidelines in the MENA Region. Insufficient resources restrict ART coverage to less than 14%, while only one fourth of the countries had reportable data on patients' CD4 counts at the time of diagnosis. Clinical guidelines need to be significantly modified to reach practical utility, and surveillance systems have not yet been developed in many countries of MENA. Based on available evidence in several countries people who inject drugs and men who have sex with men are increasingly vulnerable to HIV and viral hepatitis, while their sexual partners -either female sex workers or women in monogamous relationships with high-risk men -are potential bridging populations that are not appropriately addressed by regional programs. Research to monitor the response to ART among the mentioned groups are seriously lacking, while drug resistant HIV strains and limited information on adherence patterns to treatment regimens require urgent recognition by health policymakers. Commitment to defined goals in the fight against HIV, development of innovative methods to improve registration and reporting systems, monitoring and evaluation of current programs followed by costeffective modifications are proposed as effective steps to be acknowledged by National AIDS Programs of the countries of MENA Region. 134 MINIREVIEWSSubmit a

show abstract

HIV in the Middle East and North Africa: priority, culture, and control

Abstract: The review indicates gaps in the literature and needs for more academic engagement and political commitment. Cultural norms have notable implications for HIV control, which are discussed, considering implications for the priority, prevention, treatment, and control of HIV/AIDS.

Cited by 24 publications

References 45 publications

Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden?

Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden?

Attitudes towards premarital HIV testing among high-school students in the United Arab Emirates, and evaluation of an educational intervention

Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa

Contact Info

Product

Resources

About